Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Clinical trial NCT06354660 · COMPLETED
Trial details
- NCT number
- NCT06354660
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2026-01-22
- Enrollment
- 537
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.